Latest Administration News

Page 14 of 248
OncoSil Medical enters FY27 with FDA approval for its cancer device, rising quarterly revenue and fresh institutional funding, but its U.S. opportunity still depends on reimbursement and a tightly controlled initial rollout. Cash rose to A$8.7 million after the capital raise, while operating cash use remained substantial.
Victor Sage
Victor Sage
30 Oct 2026
Nutritional Growth Solutions has cut quarterly net operating cash outflow by 54% while completing its Sprout Organic acquisition just after quarter end. The enlarged group starts with US$1.613 million in cash, no borrowings and a substantially larger share base.
Victor Sage
Victor Sage
30 Oct 2026
Nexalis Therapeutics ended September with $371,000 in cash, equivalent to just 0.9 quarters of funding at its recent operating burn. The company has settled its dispute with Linlithgow Family Office, but its clinical programs remain paused while it pursues R&D tax funding and a new capital raise.
Ada Torres
Ada Torres
30 Oct 2026
Blackstone Minerals is moving through the pre-feasibility study for its large Mankayan copper-gold-silver project, with drilling discussions continuing and completion scheduled in FY27. The company ended September with $12.2 million in cash after using $1.6 million during the quarter, while several Vietnam milestones remain subject to government approvals.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Algorae Pharmaceuticals has moved closer to its first expected NSW Health supply orders while reporting stronger preclinical results from its AOS2 drug-discovery platform. The company ended September with $3.15 million in cash and a further $3 million undrawn facility, but its commercial contract carries no minimum volume commitment.
Victor Sage
Victor Sage
30 Oct 2026
Antilles Gold remains largely stalled in Cuba after its joint venture was designated a US Specially Designated National, with only site security continuing at Nueva Sabana. A conditional GEM deal could bring US$18 million and a path towards sanction relief, but the company ended September with just US$882,000 in cash.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Optiscan has moved its InForm and InVue medical-imaging devices into formal US FDA review after a quarter of intensive regulatory and clinical work. The milestone comes with $11.093 million in cash and a reported 3.5 quarters of funding at the latest operating burn rate.
Victor Sage
Victor Sage
30 Oct 2026
Broken Hill Mines delivered its first quarterly silver output above 100,000 ounces as three ore feeds lifted mining and processing at Rasp. The September quarter also brought A$37.6 million in sales, an A$85 million capital raise and fresh high-grade drilling results at Centenary and Pinnacles.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Blue Energy is positioning its Queensland gas portfolio for potential demand from LNG exporters under proposed federal reservation rules, while seeking a farm-in partner for ATP 854. The company ended September with A$3.2 million in unaudited cash, no debt and a more cautious approach to Sapphire spending.
Victor Sage
Victor Sage
30 Oct 2026
Clinuvel has submitted NEURACTHEL Instant for regulatory review in three initial European Union markets, opening a potential pathway for its second pharmaceutical product. The decentralised review is expected to take 300 days, excluding clock stops, but the product is not yet approved anywhere.
Victor Sage
Victor Sage
30 Oct 2026
WhiteRock Lithium has completed its 19,481-metre Spodumene Mountain drilling campaign, with assays from the first 17 holes confirming thick, high-grade lithium intersections. The ASX-listed explorer is now working towards a maiden Mineral Resource Estimate in the first half of 2027, subject to further assays and geological modelling.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Dalaroo Metals has expanded its Bondoukou campaign to a fully funded 12,000 metres after early Wilfred assays included 18 metres at 7.31 g/t gold. The September quarter also delivered four new Greenland prospects, stronger Watheroo copper-nickel targets and an A$2.5 million capital raising.
Maxwell Dee
Maxwell Dee
30 Oct 2026

Browse the archive

Full archive